Antiretroviral therapy coverage in Luxembourg
Luxembourg: Antiretroviral therapy coverage was 84.0% in 2024. ▲ Rising
Antiretroviral therapy coverage in Luxembourg, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Luxembourg recorded 84.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.2% on the previous year and up 31.2% over ten years.
Over the whole period, antiretroviral therapy coverage in Luxembourg peaked at 84.0% in 2024 and was at its lowest, 40.0%, in 2000.
Luxembourg ranks 41st of 143 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage in Luxembourg, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 40.0% | — |
| 2001 | 41.0% | +2.5% |
| 2002 | 42.0% | +2.4% |
| 2003 | 41.0% | -2.4% |
| 2004 | 42.0% | +2.4% |
| 2005 | 45.0% | +7.1% |
| 2006 | 48.0% | +6.7% |
| 2007 | 47.0% | -2.1% |
| 2008 | 50.0% | +6.4% |
| 2009 | 51.0% | +2.0% |
| 2010 | 53.0% | +3.9% |
| 2011 | 56.0% | +5.7% |
| 2012 | 59.0% | +5.4% |
| 2013 | 59.0% | +0.0% |
| 2014 | 64.0% | +8.5% |
| 2015 | 66.0% | +3.1% |
| 2016 | 68.0% | +3.0% |
| 2017 | 70.0% | +2.9% |
| 2018 | 70.0% | +0.0% |
| 2019 | 71.0% | +1.4% |
| 2020 | 72.0% | +1.4% |
| 2021 | 75.0% | +4.2% |
| 2022 | 82.0% | +9.3% |
| 2023 | 83.0% | +1.2% |
| 2024 | 84.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 44.7% | 40.0% | 51.0% | 10 |
| 2010s | 63.6% | 53.0% | 71.0% | 10 |
| 2020s | 79.2% | 72.0% | 84.0% | 5 |
Countries ranked near Luxembourg
More health data for Luxembourg
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,220 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.63 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0253 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.27 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Luxembourg?
- Antiretroviral therapy coverage in Luxembourg was 84.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Luxembourg?
- The highest recorded value was 84.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Luxembourg?
- The lowest recorded value was 40.0% in 2000.
- How does Luxembourg rank for antiretroviral therapy coverage?
- Luxembourg ranks 41st out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Luxembourg?
- Over the last ten years it is up 31.2%. The long-run trend across the full record is rising.
- Where does this Luxembourg data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.